Rethinking perioperative approaches in MIBC
Raising the Bar in Bladder Cancer Care is a three-part podcast series featuring leading experts who discuss the evolving treatment landscape in bladder cancer. Through evidence-based discussions and practical insights, the series explores treatment sequencing in advanced urothelial carcinoma, new perioperative approaches in muscle-invasive bladder cancer, and the importance of multidisciplinary strategies to optimize patient care and adverse event management.
Join Enrique Grande and Michiel van der Heijden as they review the latest evidence supporting perioperative treatment strategies in MIBC, before exploring how evolving biomarkers such as ctDNA and utDNA may help guide risk assessment, treatment selection, and future bladder-preservation strategies.
Start this program
Enrique Grande
Michiel van der Heijden
- Evaluate clinical data supporting perioperative treatment strategies for MIBC, including for immunotherapy and antibody-drug conjugate (ADC) strategies
In addition to the expert faculty, Springer Healthcare IME planners and staff include Kamran Ahmad and Rebecca Cox. The planning committee have no financial relationships to disclose.
All relevant financial relationships of the faculty have been mitigated.
Urologists, oncologists, surgeons, oncology nurses, physician assistants, pathologists and pharmacists involved in the care of patients with advanced UC and MIBC, and all other healthcare professionals (HCPs) managing bladder cancer.
Other learning activities in this program
